BME
Income statement / Annual
Last year (2025), BlackRock Health Sciences Trust's total revenue was $36.16 M,
an increase of 50.21% from the previous year.
In 2025, BlackRock Health Sciences Trust's net income was $76.97 M.
See BlackRock Health Sciences Trust,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$36.16 M |
$24.07 M |
$34.90 M |
-$25.97 M |
$53.18 M |
$80.09 M |
$0.00 |
| Cost of Revenue |
$5.63 M
|
$0.00
|
$6.02 M
|
$0.00
|
$6.11 M
|
$4.95 M
|
$0.00
|
| Gross Profit |
$30.53 M
|
$24.07 M
|
$28.87 M
|
-$25.97 M
|
$47.07 M
|
$5.24 M
|
$0.00
|
| Gross Profit Ratio |
0.84
|
1
|
0.83
|
1
|
0.89
|
0.07
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$355.53 K
|
$299.03 K
|
$362.16 K
|
$6.35 M
|
$5.17 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$355.53 K
|
$299.03 K
|
$362.16 K
|
$6.35 M
|
$5.17 M
|
$0.00
|
| Other Expenses |
-$46.46 M
|
$261.57 K
|
$94.57 K
|
-$26.33 M
|
-$5.81 M
|
$0.00
|
$0.00
|
| Operating Expenses |
-$46.46 M
|
$617.09 K
|
$393.60 K
|
-$25.97 M
|
$541.46 K
|
$5.17 M
|
$0.00
|
| Cost And Expenses |
-$40.84 M
|
$617.09 K
|
$14.87 M
|
-$25.97 M
|
-$5.95 M
|
$80.09 M
|
$0.00
|
| Interest Income |
$7.72 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$45.69 K
|
$78.00
|
$55.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$927.18 K
|
-$2.01 M
|
$228.49 K
|
-$53.94 K
|
$0.00
|
$171.86 K
|
| EBITDA |
$77.01 M |
$23.50 M |
$20.02 M |
-$26.23 M |
$59.12 M |
$79.56 M |
$0.00 |
| EBITDA Ratio |
2.13
|
0.98
|
0.57
|
1.01
|
1.11
|
0.99
|
0
|
| Operating Income Ratio |
2.13
|
0.97
|
0.24
|
1.02
|
1.11
|
0.99
|
0
|
| Total Other Income/Expenses Net |
-$27.70 K
|
$0.00
|
$11.55 M
|
-$12.32 K
|
$0.00
|
$79.56 M
|
$0.00
|
| Income Before Tax |
$76.97 M
|
$23.45 M
|
$20.02 M
|
-$26.47 M
|
$59.12 M
|
$79.56 M
|
$0.00
|
| Income Before Tax Ratio |
2.13
|
0.97
|
0.57
|
1.02
|
1.11
|
0.99
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$76.97 M
|
$23.45 M
|
$20.02 M
|
-$26.47 M
|
$59.12 M
|
$79.56 M
|
$0.00
|
| Net Income Ratio |
2.13
|
0.97
|
0.57
|
1.02
|
1.11
|
0.99
|
0
|
| EPS |
5.92 |
1.77 |
1.44 |
-2.1 |
4.74 |
6.87 |
1.45 |
| EPS Diluted |
5.92 |
1.77 |
1.44 |
-2.1 |
4.74 |
6.87 |
1.45 |
| Weighted Average Shares Out |
$13.00 M
|
$13.26 M
|
$13.94 M
|
$12.61 M
|
$112.88 M
|
$112.70 M
|
$112.70 M
|
| Weighted Average Shares Out Diluted |
$13.00 M
|
$13.26 M
|
$13.94 M
|
$12.61 M
|
$112.88 M
|
$112.70 M
|
$112.70 M
|
| Link |
|
|
|
|
|
|
|
